ReCellTis

Manufacturer
CellNovation Technology Corporation
Effective date
2018-03-21
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
legacy-cache
Hydrated at
2026-08-02 01:00:46

Label at a glance#

ProductReCellTis
Active ingredientBACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE, LIDOCAINE
Label structure9 sections

Indications and uses

First aid to prevent infection, for temporary relief of pain or discomfort, and helps promote skin repair in minor: Cuts Scrapes Burns

Dosage and administration

Adults and children 2 years of age or older: clean the affected area apply a small amount (thin layer) on the area 1 to 3 times daily may be covered with sterile bandage Children under 2 years of age: ask a doctor

Label contents#

Full prescribing information#

ReCellTis +Pain & Itch Relief First Aid Cream

SPL UNCLASSIFIED SECTION

Drug Facts

Active Ingredients (in each gram)

OTC - ACTIVE INGREDIENT SECTION

Bacitracin Zinc 400 units

Neomycin Sulfate 5mg (equivalent to 3.5 mg of neomycin base)

Polymyxin B Sulfate 5,000 units

Lidocaine Hydrochloride 20 mg

Purpose

OTC - PURPOSE SECTION

First aid antibiotic

First aid antibiotic

First aid antibiotic

Local anesthetic

Uses

INDICATIONS & USAGE SECTION

First aid to prevent infection, for temporary relief of pain or discomfort, and helps promote skin repair in minor:

  • Cuts
  • Scrapes
  • Burns

Warnings

WARNINGS SECTION

For external use only

Do not use

OTC - DO NOT USE SECTION

  • in the eyes
  • if you are allergic to any of the ingredients
  • over large areas of the body

Ask a doctor before use if you have

OTC - ASK DOCTOR SECTION

  • deep or puncture wounds
  • animal bites
  • serious burns

Stop use and ask a doctor if

OTC - STOP USE SECTION

  • you need to use longer than 1 week
  • rash or other allergic reaction develops
  • condition persists or gets worse

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children.

If swallowed, get medical help or contact a Poison Control Center immediately.

Directions

DOSAGE & ADMINISTRATION SECTION

Adults and children 2 years of age or older:

  • clean the affected area
  • apply a small amount (thin layer) on the area 1 to 3 times daily
  • may be covered with sterile bandage

Children under 2 years of age: ask a doctor

Other Information

SPL UNCLASSIFIED SECTION

  • store at 15° to 30°C (59° to 86°F)
  • protect from freezing and avoid excessive heat

Inactive ingredients

INACTIVE INGREDIENT SECTION

Carboxymethyl Cellulose, Cetostearyl Alcohol, Cetyl Alcohol, CoEnzyme Q-10, Purified Water, Phenoxyethanol, Polysorbate 80, Sorbitan Oleate, Tocopheryl Acetate , White Petrolatum, Zinc Gluconate.

PRINCIPAL DISPLAY PANEL

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

ReCellTisReCellTis

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
71929-069-322020-01-31C16284748780-19d75b9d0-964f-f424-e053-dadaa90a57ceReCellTis

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
71929-069RECELLTIS (BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE, LIDOCAINE HCL) CREAM [CELLNOVATION TECHNOLOGY CORPORATION]1Legacy NDC20180322_67f1c6b1-28a2-2b14-e053-2991aa0a656c.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 20 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
71929-06971929-069-32

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 15 matching rows.

Source Document#

Source XML · Source PDF

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
67f1c6b1-28a3-2b14-e053-2991aa0a656c67f1c6b1-28a2-2b14-e053-2991aa0a656c2018-03-21WarningsExact identifier
spl id: 67f1c6b1-28a3-2b14-e053-2991aa0a656c
spl set id: 67f1c6b1-28a2-2b14-e053-2991aa0a656c

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.